Hoang Nhat Pham

3.0k total citations
45 papers, 92 citations indexed

About

Hoang Nhat Pham is a scholar working on Cardiology and Cardiovascular Medicine, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Hoang Nhat Pham has authored 45 papers receiving a total of 92 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Cardiology and Cardiovascular Medicine, 11 papers in Epidemiology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Hoang Nhat Pham's work include Atrial Fibrillation Management and Outcomes (6 papers), Health disparities and outcomes (5 papers) and Diabetes Treatment and Management (5 papers). Hoang Nhat Pham is often cited by papers focused on Atrial Fibrillation Management and Outcomes (6 papers), Health disparities and outcomes (5 papers) and Diabetes Treatment and Management (5 papers). Hoang Nhat Pham collaborates with scholars based in United States, United Kingdom and Vietnam. Hoang Nhat Pham's co-authors include Angelo Salvucci, Sadeer Al‐Kindi, Kotoka Nakamura, Audrey Uy‐Evanado, Zijun Zhang, Kyndaron Reinier, Sumeet S. Chugh, Lauri Holmström, Jonathan Jui and Harpriya Chugh and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Hoang Nhat Pham

27 papers receiving 90 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hoang Nhat Pham United States 5 47 18 9 9 9 45 92
Cristina Maldonado‐Araque Spain 5 26 0.6× 27 1.5× 12 1.3× 9 1.0× 30 3.3× 10 141
Lilia Zakhama Tunisia 5 25 0.5× 8 0.4× 10 1.1× 19 2.1× 8 0.9× 42 69
E. I. Tarlovskaya Russia 5 62 1.3× 45 2.5× 12 1.3× 14 1.6× 5 0.6× 49 132
Niamh Chapman Australia 7 88 1.9× 6 0.3× 23 2.6× 11 1.2× 36 4.0× 36 155
Yu. L. Begrambekova Russia 8 61 1.3× 23 1.3× 6 0.7× 12 1.3× 7 0.8× 34 154
Neema W. Minja United States 4 50 1.1× 25 1.4× 17 1.9× 6 0.7× 33 3.7× 6 101
K. Stamatelopoulos Greece 7 67 1.4× 8 0.4× 21 2.3× 10 1.1× 2 0.2× 13 119
Ângelo Amato Vicenzo de Paola Brazil 5 38 0.8× 11 0.6× 9 1.0× 6 0.7× 13 1.4× 6 81
A.A. Akintunde Nigeria 5 37 0.8× 23 1.3× 7 0.8× 10 1.1× 22 2.4× 8 81

Countries citing papers authored by Hoang Nhat Pham

Since Specialization
Citations

This map shows the geographic impact of Hoang Nhat Pham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hoang Nhat Pham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hoang Nhat Pham more than expected).

Fields of papers citing papers by Hoang Nhat Pham

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hoang Nhat Pham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hoang Nhat Pham. The network helps show where Hoang Nhat Pham may publish in the future.

Co-authorship network of co-authors of Hoang Nhat Pham

This figure shows the co-authorship network connecting the top 25 collaborators of Hoang Nhat Pham. A scholar is included among the top collaborators of Hoang Nhat Pham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hoang Nhat Pham. Hoang Nhat Pham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pham, Hoang Nhat, Mahmoud Abdelnabi, Juan Farina, et al.. (2025). GLP-1 receptor agonists and clinical outcomes in patients with type 2 diabetes undergoing transcatheter aortic valve implantation. European Heart Journal - Quality of Care and Clinical Outcomes.
2.
Lim, Gerald, Mahmoud Abdelnabi, Hoang Nhat Pham, et al.. (2025). Sodium‐Glucose Cotransporter‐2 Inhibitors and Stroke Risk in Patients With Atrial Fibrillation. Journal of Cardiovascular Electrophysiology. 36(8). 1826–1835.
3.
Wang, Winston, Mahmoud Abdelnabi, Hoang Nhat Pham, et al.. (2025). Navigating Sarcopenia Risks in GLP-1RA Therapy for Advanced Heart Failure. Biomedicines. 13(5). 1108–1108. 2 indexed citations
4.
Pham, Hoang Nhat, Mahmoud Abdelnabi, Amitoj Singh, et al.. (2025). Exercise and Atrial Fibrillation: Current Evidence, Knowledge Gaps, and Future Directions. Reviews in Cardiovascular Medicine. 26(7). 39200–39200.
5.
Falco, D. de, G. Negri, Hoang Nhat Pham, et al.. (2025). Desmosomal Versus Non-Desmosomal Arrhythmogenic Cardiomyopathies: A State-of-the-Art Review. SHILAP Revista de lepidopterología. 15(3). 22–22. 1 indexed citations
6.
Pham, Hoang Nhat, et al.. (2024). Interstitial Lung Disease Mortality Disparities Along the US-Mexico Border, 1999-2020. CHEST Journal. 166(6). 1455–1462. 1 indexed citations
7.
Pham, Hoang Nhat, et al.. (2024). Ischemic heart disease mortality in individuals with inflammatory bowel disease: A nationwide analysis of disparities in the United States. Cardiovascular revascularization medicine. 65. 46–51. 1 indexed citations
8.
9.
Pham, Hoang Nhat, et al.. (2024). Big Data, Big Insights: Leveraging Data Analytics to Unravel Cardiovascular Exposome Complexities. Methodist DeBakey Cardiovascular Journal. 20(5). 111–123.
10.
Pham, Hoang Nhat, et al.. (2024). Pharmacological management of transthyretin amyloid cardiomyopathy: a scoping review. European Heart Journal - Cardiovascular Pharmacotherapy. 10(6). 547–556.
11.
Pham, Hoang Nhat, et al.. (2024). Advances in Atrial Fibrillation Management: A Guide for General Internists. Journal of Clinical Medicine. 13(24). 7846–7846. 3 indexed citations
12.
Pham, Hoang Nhat, et al.. (2024). Lung cancer mortality trends and disparities: A cross-sectional analysis 1999–2020. Cancer Epidemiology. 92. 102652–102652. 1 indexed citations
13.
Pham, Hoang Nhat, et al.. (2024). Managing Obesity in Heart Failure: Latest Evidence and Knowledge Gaps. Current Treatment Options in Cardiovascular Medicine. 26(12). 355–367. 3 indexed citations
14.
Holmström, Lauri, Harpriya Chugh, Hoang Nhat Pham, et al.. (2024). Artificial Intelligence Model Predicts Sudden Cardiac Arrest Manifesting With Pulseless Electric Activity Versus Ventricular Fibrillation. Circulation Arrhythmia and Electrophysiology. 17(2). e012338–e012338. 12 indexed citations
15.
Shah, Prakesh S., Mai Luu, Zeeshan Ali Khan, et al.. (2023). Efficacy and safety of fenofibrate in combination with phototherapy for the treatment of neonatal hyperbilirubinemia: A systematic review and meta-analyses.. Canadian Journal of Physiology and Pharmacology. 102(4). 242–253. 2 indexed citations
16.
Pham, Hoang Nhat, Lauri Holmström, Harpriya Chugh, et al.. (2023). Dynamic electrocardiogram changes are a novel risk marker for sudden cardiac death. European Heart Journal. 45(10). 809–819. 15 indexed citations
17.
Pham, Hoang Nhat, et al.. (2023). Alcoholic cardiomyopathy mortality and social vulnerability index: A nationwide cross-sectional analysis. International Journal of Cardiology Cardiovascular Risk and Prevention. 19. 200224–200224. 5 indexed citations
18.
Pham, Hoang Nhat, et al.. (2023). POTENTIAL CAUSES OF SUDDEN CARDIAC ARREST IN A PATIENT WITH COVID-19. Journal of the American College of Cardiology. 81(8). 3269–3269.
19.
Pham, Hoang Nhat, et al.. (2023). Regional Disparities and Death Trends Related to Hemopericardial Cardiovascular Mortality. The American Journal of Cardiology. 210. 8–10. 2 indexed citations
20.
Pham, Hoang Nhat, et al.. (2023). Social Vulnerability and Hemopericardial Cardiovascular Death: Insight from the Centers for Disease Control and Prevention Databases. The American Journal of Cardiology. 210. 143–145. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cristina Maldonado‐Araque Breakdown of academic impact, for papers by Lilia Zakhama Breakdown of academic impact, for papers by E. I. Tarlovskaya Breakdown of academic impact, for papers by Niamh Chapman Breakdown of academic impact, for papers by Yu. L. Begrambekova Breakdown of academic impact, for papers by Neema W. Minja Breakdown of academic impact, for papers by K. Stamatelopoulos Breakdown of academic impact, for papers by Ângelo Amato Vicenzo de Paola Breakdown of academic impact, for papers by A.A. Akintunde
Rankless by CCL
2026